Yoshitaka Kitao

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI Financial Services Co., Ltd. operates as an intermediary holding company that engages in the financial service business. The company was founded in June 2012 and is headquartered in Tokyo, Japan.

SBI Financial Services Co., Ltd. operates as an intermediary holding company that engages in the financial service business. The company was founded in June 2012 and is headquartered in Tokyo, Japan.

Part of SBI Holdings, Inc., SBI Capital Management Co., Ltd. engages in asset management business. The private company is based in Tokyo, Japan.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

Founded in 2014, SBI Global Asset Management Co., Ltd. is a subsidiary of SBI Holdings, Inc. that provides asset and business management services. The private company is based in Tokyo, Japan.

ICCP SBI Venture Partners (ISVP) is a venture capital division of Investment & Capital Corp. of the Philippines founded in 1997 by Guillermo D Luchangco. The firm headquartered in Makati City, Philippines.

SBI Japannext Co., Ltd. operates an online trading system. It creates a proprietary trading system venue to replicate the electronic connection networks in the United States serving as an after-hours market for online users. The company was founded on November 8, 2006 and is headquartered in Tokyo, Japan.

SBI Virtual Currencies KK provides virtual currency exchange and transaction services. The company was founded on November 1, 2016 and is headquartered in Tokyo, Japan.

SBI Liquidity Market Co., Ltd. engages in the provision of market functions and services related to foreign exchange margin trading. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

Part of SBI Holdings, Inc., SBI Korea Holdings Co., Ltd. is an investment holding South Korean company. The private company is based in Seoul, South Korea. Yoshimi Takahashi has been the CEO of the company since 2002.

SBI Virtual Currencies KK provides virtual currency exchange and transaction services. The company was founded on November 1, 2016 and is headquartered in Tokyo, Japan.

SBI Japannext Co., Ltd. operates an online trading system. It creates a proprietary trading system venue to replicate the electronic connection networks in the United States serving as an after-hours market for online users. The company was founded on November 8, 2006 and is headquartered in Tokyo, Japan.

SBI Pharmaceuticals Co., Ltd. engages in the distribution of medical supplies, cosmetics, and health foods. The firm also offers medicines, medical devices, and animal feed. The company was founded on April 18, 2008 and is headquartered in Tokyo, Japan.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI Liquidity Market Co., Ltd. engages in the provision of market functions and services related to foreign exchange margin trading. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

ICCP SBI Venture Partners (ISVP) is a venture capital division of Investment & Capital Corp. of the Philippines founded in 1997 by Guillermo D Luchangco. The firm headquartered in Makati City, Philippines.

ICCP SBI Venture Partners (ISVP) is a venture capital division of Investment & Capital Corp. of the Philippines founded in 1997 by Guillermo D Luchangco. The firm headquartered in Makati City, Philippines.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

ICCP SBI Venture Partners (ISVP) is a venture capital division of Investment & Capital Corp. of the Philippines founded in 1997 by Guillermo D Luchangco. The firm headquartered in Makati City, Philippines.

SBI Virtual Currencies KK provides virtual currency exchange and transaction services. The company was founded on November 1, 2016 and is headquartered in Tokyo, Japan.

SBI Liquidity Market Co., Ltd. engages in the provision of market functions and services related to foreign exchange margin trading. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SoftBank Holdings, Inc. engages in gathering information on Internet-related companies with a view to strategic investment. The company was founded in March 1994 and is headquartered in Wilmington, DE.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

ICCP SBI Venture Partners (ISVP) is a venture capital division of Investment & Capital Corp. of the Philippines founded in 1997 by Guillermo D Luchangco. The firm headquartered in Makati City, Philippines.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

ICCP SBI Venture Partners (ISVP) is a venture capital division of Investment & Capital Corp. of the Philippines founded in 1997 by Guillermo D Luchangco. The firm headquartered in Makati City, Philippines.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

SBI Liquidity Market Co., Ltd. engages in the provision of market functions and services related to foreign exchange margin trading. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

SBI Liquidity Market Co., Ltd. engages in the provision of market functions and services related to foreign exchange margin trading. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

SBI Liquidity Market Co., Ltd. engages in the provision of market functions and services related to foreign exchange margin trading. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

SBI Investment Co., Ltd. (SBI Investment) is a wholly-owned subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI Japannext Co., Ltd. operates an online trading system. It creates a proprietary trading system venue to replicate the electronic connection networks in the United States serving as an after-hours market for online users. The company was founded on November 8, 2006 and is headquartered in Tokyo, Japan.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI Virtual Currencies KK provides virtual currency exchange and transaction services. The company was founded on November 1, 2016 and is headquartered in Tokyo, Japan.

SBI Virtual Currencies KK provides virtual currency exchange and transaction services. The company was founded on November 1, 2016 and is headquartered in Tokyo, Japan.

SBI Securities Co., Ltd. is the broker/dealer subsidiary of SBI Financial Services Co. Ltd., itself a subsidiary of SBI Holdings, Inc. (TYO: 8473) in Japan. The firm was founded in 1944 as SBI eTrade Securities Co., Ltd. and changed their name to SBI Securities Co., Ltd. in 2008. Headquartered in Tokyo, SBI Securities provides securities trading, underwriting and private placement services, which are offered through the Internet and call centers. Besides domestic stocks, the product lineup extends to investment trusts, foreign stocks, futures and options, FX (foreign exchange margin trading), domestic and foreign bonds, etc. to meet the various needs of investors, supporting efficient fund management of individual investors.

SBI Japannext Co., Ltd. operates an online trading system. It creates a proprietary trading system venue to replicate the electronic connection networks in the United States serving as an after-hours market for online users. The company was founded on November 8, 2006 and is headquartered in Tokyo, Japan.